| Source HCPCS Code |
|
Target NDC Code |
Q5113
Inj, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
|
⇄
|
63459-0303-43
HERZUMA 150 MG VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5113
Inj, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
|
⇄
|
63459-0305-47
HERZUMA 420 MG VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
Q5113
Inj herzuma 10 mg
|
⇄
|
63459-0303-43
Herzuma
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5113
Inj herzuma 10 mg
|
⇄
|
63459-0305-47
Herzuma
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|